LifeVantage Co. (NASDAQ:LFVN) Stake Increased by Hillsdale Investment Management Inc.

Hillsdale Investment Management Inc. raised its stake in shares of LifeVantage Co. (NASDAQ:LFVN) by 7.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,720 shares of the company’s stock after acquiring an additional 1,000 shares during the quarter. Hillsdale Investment Management Inc. owned approximately 0.12% of LifeVantage worth $258,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in LFVN. HighTower Advisors LLC acquired a new stake in shares of LifeVantage in the 3rd quarter valued at about $638,000. Barclays PLC raised its stake in LifeVantage by 38.2% during the third quarter. Barclays PLC now owns 41,966 shares of the company’s stock valued at $507,000 after buying an additional 11,608 shares in the last quarter. Ritholtz Wealth Management lifted its holdings in LifeVantage by 65.2% during the 4th quarter. Ritholtz Wealth Management now owns 47,348 shares of the company’s stock worth $830,000 after buying an additional 18,682 shares during the last quarter. Copeland Capital Management LLC acquired a new position in shares of LifeVantage in the 4th quarter worth approximately $65,000. Finally, Bank of New York Mellon Corp increased its holdings in shares of LifeVantage by 43.9% in the 4th quarter. Bank of New York Mellon Corp now owns 74,183 shares of the company’s stock valued at $1,300,000 after acquiring an additional 22,620 shares during the last quarter. 35.32% of the stock is owned by institutional investors and hedge funds.

LifeVantage Trading Up 0.6 %

Shares of NASDAQ LFVN opened at $15.56 on Tuesday. LifeVantage Co. has a 12-month low of $5.22 and a 12-month high of $27.38. The company has a market cap of $195.29 million, a price-to-earnings ratio of 27.79 and a beta of 0.74. The stock’s 50 day simple moving average is $19.36 and its 200 day simple moving average is $15.84.

LifeVantage (NASDAQ:LFVN) last posted its earnings results on Wednesday, February 5th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.08. LifeVantage had a return on equity of 34.29% and a net margin of 3.46%.

LifeVantage Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Monday, March 3rd were given a $0.04 dividend. This represents a $0.16 annualized dividend and a yield of 1.03%. The ex-dividend date was Monday, March 3rd. LifeVantage’s dividend payout ratio (DPR) is 28.57%.

Insider Buying and Selling at LifeVantage

In related news, Director Raymond B. Greer sold 8,000 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $20.15, for a total value of $161,200.00. Following the completion of the transaction, the director now directly owns 99,288 shares of the company’s stock, valued at $2,000,653.20. This represents a 7.46 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 20.65% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on LFVN shares. Lake Street Capital began coverage on shares of LifeVantage in a report on Thursday, December 19th. They issued a “buy” rating and a $26.00 price objective for the company. Craig Hallum began coverage on shares of LifeVantage in a research report on Tuesday, January 14th. They set a “buy” rating and a $35.00 price objective for the company.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.